Highlights
NASDAQ: ALNY       Alnylam Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
90.58   -0.27 (0.30%)  89.75 - 91.95  669,800

Overview

 
Avg Volume (4 weeks):611,571
4 Weeks Range:80.39 - 93.98
4 Weeks Price Volatility (%):
74.98%
52 Weeks Range:60.27 - 96.08
52 Weeks Price Volatility (%):
84.64%
Average Price Target: 42.00
Price Target Upside/Downside: -48.58

Headlines



No recent Headlines for this stock.


Business Background

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgalactosamine (GalNAc)-conjugate platform for delivery of small interfering RNAs (siRNAs). Its pipeline of investigational RNAi therapeutics focuses on three Strategic Therapeutic Areas (STArs): Genetic Medicines, with multiple product candidates for the treatment of rare diseases; Cardio-Metabolic Diseases, with product candidates directed toward genetically validated, liver-expressed disease targets for unmet needs in cardiovascular and metabolic diseases, and Hepatic Infectious Diseases, with product candidates designed to address the global health challenges of hepatic infectious diseases, beginning with hepatitis B and hepatitis D viral infections. The Company's lead product, Patisiran, is formulated utilizing lipid nanoparticles (LNPs).

  Be the first to like this.
 


 

4486  3499  717  224 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.81+0.265 
 AMD 37.52+0.81 
 EEM 42.76-0.33 
 ET 11.16-0.50 
 GE 11.29-0.13 
 SPY 309.10+0.10 
 BAC 32.79-0.30 
 DIS 148.72+10.14 
 XLF 29.61-0.19 
Partners & Brokers